Warfarin in Primary Care: Practical Basics, Dose Adjustments, and When to Choose a DOAC

You inherit a patient who's already on warfarin, and now you're the one managing the INR. Some of these patients have a coumadin clinic, but plenty rely on their PCP. Here's a clinic-friendly guide you can use today.

DOACs like apixaban and rivaroxaban are often easier to manage, but warfarin isn't going away. It's still the right drug for patients with mechanical valves, antiphospholipid syndrome, severe kidney or liver disease, or cost barriers.

DOACs vs. warfarin at a glance

For most nonvalvular AF or VTE patients, a DOAC is preferred when it's affordable and clinically appropriate. For the full switch workflow, see transitioning from warfarin to a DOAC.

Common indications for warfarin

• Atrial fibrillation
• Venous thromboembolism (DVT/PE) treatment and secondary prevention
• Mechanical (prosthetic) heart valves
• Antiphospholipid syndrome
• Selected cases: heart failure, post-ACS, stroke (per specialist guidance)

Targets, monitoring, and workflow

INR goal:

• 2.0 to 3.0 for most indications
• 2.5 to 3.5 for some mechanical valves or per cardiology/hematology

Standing orders help. I place a standing INR order for 12 months so patients can draw as needed.

How often to check:

• Stable patients: every 4 weeks
• After any dose change or out-of-range result: weekly until therapeutic
• Remember, it takes about 48 to 72 hours for an INR to reflect a dose change.

Patient education:

• Keep vitamin K intake consistent. Don't ban greens, just keep them steady.
• Review new meds, especially antibiotics, antifungals, amiodarone, SSRIs, NSAIDs, and herbals.
• Go over bleeding signs and when to call.

A percent-change approach to dose adjustments

There's no single universal protocol. A simple method is to adjust the total weekly dose by a percentage based on the INR, then redistribute it across the week.

Typical adjustment ranges (a guide, not gospel):

• INR less than or equal to 1.5: increase total weekly dose about 15%
• INR 1.51 to 1.99: increase about 10%
• INR 2.0 to 3.0: no change
• INR 3.01 to 4.0: decrease about 10%
• INR 4.01 to 4.99: hold 1 dose, then restart with a decrease of about 10%
• INR 5 to 8.99: hold until INR 2 to 3, then restart with a decrease of about 15%. Always use clinical judgment and consider bleeding risk. Manage urgently if there's major bleeding or the INR is 9 or higher.

Worked example

• Current total: 30 mg/week with an INR of 1.8
• Plan: increase by 10%, so 30 x 0.10 = +3 mg
• New weekly total: 33 mg/week
• How to schedule: 5 mg on 6 days and 3 mg on 1 day, or 5 mg on 5 days plus 4 mg on 2 days.
• Recheck INR in 1 week.

Document the weekly total in your note and message the patient a day-by-day plan. It cuts down on errors.

Starting warfarin when you have to

I rarely start warfarin in primary care, but when it's needed:

• Consider a validated tool like WarfarinDosing.org for starting doses.
• Avoid loading doses in most outpatients.
• Overlap with parenteral anticoagulation for acute VTE until the INR is therapeutic per guideline.

When I try to switch to a DOAC

• Nonvalvular AF or VTE where renal and hepatic function is adequate, there are no strong drug interactions, and cost or coverage is reasonable.
• Shared decision-making: fewer interactions, no INR checks, and often a lower intracranial bleeding risk.

Safety reminders

• Pregnancy: warfarin is teratogenic. Avoid it and use specialist guidance.
• Procedures: have a peri-procedural plan with hold times and bridging based on risk and specialty input.
• Alcohol: heavy use raises bleeding risk and destabilizes the INR.

Follow-up script you can paste in your EMR

"Your goal INR is 2.0 to 3.0. Keep your vitamin K intake consistent and don't make big changes in greens. Report any new meds, antibiotics, or supplements. Watch for bleeding such as black stools, nosebleeds, or easy bruising. We adjusted your weekly dose to __ mg/week: Sun __ / Mon __ / Tue __ / Wed __ / Thu __ / Fri __ / Sat __. Recheck INR in 1 week."

References and resources

• CHEST/ACCP guidance on antithrombotic therapy (warfarin management, peri-procedural care).
• AHA/ACC/HRS guidance for atrial fibrillation anticoagulation.
• ISTH guidance on DOAC use.
• UpToDate: practical warfarin management; DOAC selection and dosing.
• WarfarinDosing.org for evidence-based initiation and adjustment support.

Frequently asked questions

How fast does the INR respond to a dose change?
It takes about 48 to 72 hours to reflect a change, so recheck about a week out rather than the next day. Chasing it too soon leads to over-adjusting.

Do I have to tell patients to avoid greens?
No. The goal is consistent vitamin K, not zero. Big swings in leafy greens are what destabilize the INR, so steady intake is the message.

When is warfarin still the right choice over a DOAC?
Mechanical valves, antiphospholipid syndrome, severe kidney or liver disease, and cost barriers. Those patients stay on warfarin.

There are no universally accepted outpatient dosing protocols, so pick a consistent method, communicate clearly, and recheck INRs promptly after adjustments. For a one-page version to keep at your desk, the Clinical Desk Reference covers anticoagulation basics, and the Primary Care Clinical Mastery Program goes deeper when you want it. When it fits the patient, talk through switching to a DOAC.

Education only. Use clinical judgment and your local guidelines.